| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |